Skip to content
Open Data Finder
Open Government Canada

Notice: Prescription Drug List (PDL): Multiple Additions (2020-02-13)

Published by Health Canada | Santé Canada

About this dataset

The purpose of this Notice of Amendment is to notify about the additions of gemtuzumab ozogamacin, gilteritinib, icosapent ethyl, tafamidis, trifarotine and upadacitinib to the Prescription Drug List (PDL) for human and/or veterinary use.

Notice: Prescription Drug List (PDL): Multiple Additions (2020-02-13) · Open Data Finder